BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1465485)

  • 1. Metastasis of unknown origin.
    Perchalski JE; Hall KL; Dewar MA
    Prim Care; 1992 Dec; 19(4):747-57. PubMed ID: 1465485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignancies of undetermined primary origin.
    Bitran JD; Ultmann JE
    Dis Mon; 1992 Apr; 38(4):213-60. PubMed ID: 1547698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic adeno or undifferentiated carcinoma from an unknown primary site--natural history and guidelines for identification of treatable subsets.
    Kirsten F; Chi CH; Leary JA; Ng AB; Hedley DW; Tattersall MH
    Q J Med; 1987 Feb; 62(238):143-61. PubMed ID: 3659256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The need to consider survival, outcome, and expense when evaluating and treating patients with unknown primary carcinoma.
    Schapira DV; Jarrett AR
    Arch Intern Med; 1995 Oct; 155(19):2050-4. PubMed ID: 7575063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment of unknown primary tumors].
    Dodion P; De Valeriola D
    Bull Cancer; 1989; 76(9):939-46. PubMed ID: 2695183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary tumor site.
    Hainsworth JD; Greco FA
    Semin Oncol; 1993 Jun; 20(3):279-86. PubMed ID: 8503024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 'Sentinel Node' Concept: More Questions Raised than Answers Provided?
    Schlag PM
    Oncologist; 1998; 3(5):VI-VII. PubMed ID: 10388128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Unknown primary cancer].
    Furue H
    Gan To Kagaku Ryoho; 1998 Jan; 25(1):1-6. PubMed ID: 9464322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating localized prostate cancer and identifying candidates for focal therapy.
    Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
    Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy.
    Miller FR; Karnad AB; Eng T; Hussey DH; Stan McGuff H; Otto RA
    Head Neck; 2008 Jan; 30(1):28-34. PubMed ID: 17657782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer of unknown primary site.
    Schlag PM; Hünerbein M
    Ann Chir Gynaecol; 1994; 83(1):8-12. PubMed ID: 8053645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The analysis of physicians' work: announcing the end of attempts at in vitro fertilization].
    Santiago-Delefosse M; Cahen F; Coeffin-Driol C
    Encephale; 2003; 29(4 Pt 1):293-305. PubMed ID: 14615699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Liver metastases with unknown primary site].
    Drug VL; Popa I; Cijevschi C; Miron L; Mitrică D; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(2):298-305. PubMed ID: 14755931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical and ablative treatment for metastatic adenocarcinoma to the liver from unknown primary tumor.
    Hawksworth J; Geisinger K; Zagoria R; Kavanagh P; Howerton R; Levine EA; Shen P
    Am Surg; 2004 Jun; 70(6):512-7. PubMed ID: 15212405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm.
    Dennis JL; Hvidsten TR; Wit EC; Komorowski J; Bell AK; Downie I; Mooney J; Verbeke C; Bellamy C; Keith WN; Oien KA
    Clin Cancer Res; 2005 May; 11(10):3766-72. PubMed ID: 15897574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.